CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
46.30
-0.68 (-1.45%)
At close: Jul 31, 2026, 4:00 PM EDT
46.05
-0.25 (-0.54%)
After-hours: Jul 31, 2026, 7:34 PM EDT
CONMED Revenue
CONMED had revenue of $343.49M in the quarter ending June 30, 2026, with 0.33% growth. This brings the company's revenue in the last twelve months to $1.37B, up 3.42% year-over-year. In the year 2025, CONMED had annual revenue of $1.37B with 5.18% growth.
Revenue (ttm)
$1.37B
Revenue Growth
+3.42%
P/S Ratio
1.01
Revenue / Employee
$351,707
Employees
3,900
Market Cap
1.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 67.71M | 5.18% |
| Dec 31, 2024 | 1.31B | 62.27M | 5.00% |
| Dec 31, 2023 | 1.24B | 199.27M | 19.06% |
| Dec 31, 2022 | 1.05B | 34.84M | 3.45% |
| Dec 31, 2021 | 1.01B | 148.18M | 17.18% |
| Dec 31, 2020 | 862.46M | -92.64M | -9.70% |
| Dec 31, 2019 | 955.10M | 95.46M | 11.11% |
| Dec 31, 2018 | 859.63M | 63.24M | 7.94% |
| Dec 31, 2017 | 796.39M | 32.87M | 4.31% |
| Dec 31, 2016 | 763.52M | 44.35M | 6.17% |
| Dec 31, 2015 | 719.17M | -20.89M | -2.82% |
| Dec 31, 2014 | 740.06M | -22.65M | -2.97% |
| Dec 31, 2013 | 762.70M | -4.44M | -0.58% |
| Dec 31, 2012 | 767.14M | 42.06M | 5.80% |
| Dec 31, 2011 | 725.08M | 11.35M | 1.59% |
| Dec 31, 2010 | 713.72M | 18.98M | 2.73% |
| Dec 31, 2009 | 694.74M | -47.44M | -6.39% |
| Dec 31, 2008 | 742.18M | 47.90M | 6.90% |
| Dec 31, 2007 | 694.29M | 47.48M | 7.34% |
| Dec 31, 2006 | 646.81M | 29.51M | 4.78% |
| Dec 31, 2005 | 617.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.29B |
| QuidelOrtho | 2.66B |
| Enovis | 2.28B |
| Integra LifeSciences Holdings | 1.65B |
| Tandem Diabetes Care | 1.03B |
| Inspire Medical Systems | 915.25M |
| Alphatec Holdings | 787.08M |
| NovoCure | 699.19M |
CNMD News
- 3 days ago - Conmed price target raised to $45 from $40 at JPMorgan - TheFly
- 3 days ago - Conmed price target raised to $45 from $39 at Piper Sandler - TheFly
- 3 days ago - CONMED Earnings Call Transcript: Q2 2026 - Transcripts
- 3 days ago - CONMED Earnings release: Q2 2026 - Filings
- 3 days ago - CONMED Slides: Q2 2026 - Filings
- 3 days ago - CONMED Quarterly report: Q2 2026 - Filings
- 3 days ago - Conmed reports Q2 adjusted EPS $1.38, consensus $1.11 - TheFly
- 3 days ago - Conmed raises FY26 EPS view to $4.48-$4.60 from $4.30-$4.45, consensus $4.34 - TheFly